Synthesis and biological evaluation of novel SIPI-7623 derivatives as farnesoid X receptor (FXR) antagonists

被引：0
|
作者：
Si-Yun Nian
Guo-Ping Wang
Zheng-Li Jiang
Ying Xiao
Mo-Han Huang
Yi-Huan Zhou
Xiang-Duan Tan
机构：
[1] Taizhou Hospital of Zhejiang Province,Department of Clinical Pharmacy
[2] China State Institute of Pharmaceutical Industry,Shanghai Institute of Pharmaceutical Industry
[3] Aurisco Pharmaceutical (Yangzhou) Co.,College of Pharmacy
[4] Ltd.,undefined
[5] Guilin Medical University,undefined
来源：
Molecular Diversity | 2019年 / 23卷
关键词：
FXR antagonists; Guggulsterone; Structure activity relationship; Molecular docking;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Most of reported steroidal FXR antagonists are restricted due to low potency. We described the design and synthesis of novel nonsteroidal scaffold SIPI-7623 derivatives as FXR antagonists. The most potent compound A-11 (IC50 = 7.8 ± 1.1 μM) showed better activity compared to SIPI-7623 (IC50 = 40.8 ± 1.7 μM) and guggulsterone (IC50 = 45.9 ± 1.1 μM). Docking of A-11 in FXR’s ligand-binding domain was also studied.
引用
收藏
页码：19 / 33
页数：14
相关论文
共 50 条
  • [31] Design, synthesis, and biological evaluation of benzofuran derivatives as ET receptor antagonists
    Jin Cai
    Junqing Chen
    Meng Cao
    Peng Wang
    Chengliang Feng
    Min Ji
    Medicinal Chemistry Research, 2013, 22 : 5472 - 5480
  • [32] Novel FXR (farnesoid X receptor) modulators: Potential therapies for cholesterol gallstone disease
    Yu, Donna D.
    Andrali, Sreenath S.
    Li, Hongzhi
    Lin, Min
    Huang, Wendong
    Forman, Barry M.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 3986 - 3993
  • [33] Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists
    Wu, Tian-Ming
    Wang, Dao-Cai
    Xiang, Pu
    Zhang, Jian-Nan
    Sang, Ya-Xiong
    Lin, Hong-Jun
    Chen, Jie
    Xie, Gang
    Song, Hang
    Zhao, Ying-Lan
    Xie, Yong-Mei
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (05) : 1426 - 1431
  • [34] Design, Synthesis and Biological Evaluation of Novel Ketamine Derivatives as NMDAR Antagonists
    Li, Shiyun
    Wen, Bin
    Zhao, Wei
    Wang, Lulu
    Chen, Xingquan
    MOLECULES, 2024, 29 (11):
  • [35] A2B adenosine receptor antagonists: Design, synthesis and biological evaluation of novel xanthine derivatives
    Basu, Sujay
    Barawkar, Dinesh A.
    Ramdas, Vidya
    Waman, Yogesh
    Patel, Meena
    Panmand, Anil
    Kumar, Santosh
    Thorat, Sachin
    Bonagiri, Rajesh
    Jadhav, Dilip
    Mukhopadhyay, Partha
    Prasad, Vandna
    Reddy, B. Srinivasa
    Goswami, Arnab
    Chaturvedi, Sandhya
    Menon, Suraj
    Quraishi, Azfar
    Ghosh, Indraneel
    Dusange, Sushant
    Paliwal, Shalini
    Kulkarni, Abhay
    Karande, Vikas
    Thakre, Rhishikesh
    Bedse, Gaurav
    Rouduri, Sreekanth
    Gundu, Jayasagar
    Palle, Venkata P.
    Chugh, Anita
    Mookhtiar, Kasim A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 127 : 986 - 996
  • [36] Nonacidic Chemotype Possessing N-Acylated Piperidine Moiety as Potent Farnesoid X Receptor (FXR) Antagonists
    Teno, Naoki
    Yamashita, Yukiko
    Ig, Yusuke
    Fujimori, Ko
    Une, Mizuho
    Nishimaki-Mogami, Tomoko
    Hiramoto, Takie
    Gohda, Keigo
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (02): : 78 - 83
  • [37] Synthesis and biological evaluation of novel, selective, nonsteroidal glucocorticoid receptor antagonists
    Akritopoulou-Zanze, I
    Patel, JR
    Hartandi, K
    Brenneman, J
    Winn, M
    Pratt, JK
    Grynfarb, M
    Goos-Nisson, A
    von Geldern, TW
    Kym, PR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (09) : 2079 - 2082
  • [38] Synthesis and pharmacological evaluation of indolinone derivatives as novel ghrelin receptor antagonists
    Puleo, Letizia
    Marini, Pietro
    Avallone, Roberta
    Zanchet, Marco
    Bandiera, Silvio
    Baroni, Marco
    Croci, Tiziano
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (18) : 5623 - 5636
  • [39] Design, synthesis and biological evaluation of aminobenzyloxyarylamide derivatives as selective κ opioid receptor antagonists
    Wang, Junwei
    Song, Qiao
    Xu, Anhua
    Bao, Yu
    Xu, Yungen
    Zhu, Qihua
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 130 : 15 - 25
  • [40] Discovery of novel, highly potent and selective small molecule farnesoid X receptor (FXR) agonists
    Richter, Hans G. F.
    Benson, Gregory M.
    Bleicher, Konrad H.
    Blum, Denise
    Chaput, Evelyne
    Clemann, Nicole
    Feng, Song
    Gardes, Christophe
    Grether, Uwe
    Hartman, Peter
    Kuhn, Bernd
    Martin, Rainer E.
    Plancher, Jean-Marc
    Rudolph, Markus
    Schuler, Franz
    Taylor, Sven
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
12345